Senti Biosciences Inc. (SNTI)

AI Score

Unlock

4.33

0.29 (7.18%)

At close: Apr 23, 2025, 3:59 PM

4.45

2.65%

Pre-market: Apr 24, 2025, 09:25 AM EDT

Senti Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	48.28M	10.48M	15.86M	23.72M	35.93M	39.43M	36.75M	31.6M	57.62M	114.94M	139.8M	396.69K	56.03M	984.54K	1.1M	-30.56M	30.54M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	652K	22.88M	44.51M	40.94M	1.64M	983K	1.32M	1.16M	n/a	n/a	61.12M	25K
Long-Term Investments	n/a	n/a	3.55M	4.41M	4.64M	7.45M	3.34M	3.55M	3.37M	n/a	3.26M	230.03M	230.01M	230M	230M	n/a	n/a
Other Long-Term Assets	3.64M	3.65M	474K	1.96M	2.03M	1.85M	393K	471K	293K	3.54M	207K	-44.19M	-226.58M	-26.55M	n/a	373.66K	-16.14M
Receivables	1.8M	74K	18.66M	17.92M	17.7M	18.62M	567K	791K	626K	846K	573K	n/a	483K	433K	n/a	n/a	317K
Inventory	n/a	n/a	n/a	n/a	n/a	-39.58M	3.15M	3.5M	3.29M	1.00	3.52M	-430K	2.6M	-433K	n/a	n/a	n/a
Other Current Assets	10.53M	6.83M	107K	n/a	237K	1.14M	1.42M	1.41M	1.52M	1.7M	1.01M	430.46K	1.72M	n/a	n/a	n/a	830K
Total Current Assets	58.96M	17.38M	44.34M	55.67M	71.2M	79.01M	63.49M	80.51M	102.58M	119.76M	143.92M	827.15K	60.19M	1.66M	1.88M	30.56M	31.71M
Property-Plant & Equipment	35.24M	36.69M	38.55M	40.15M	41.61M	43.45M	76.41M	76.89M	74.55M	66.14M	54.98M	44.24M	33.08M	26.55M	n/a	n/a	16.14M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	38.88M	40.34M	42.57M	46.52M	48.28M	52.76M	80.14M	80.91M	78.21M	69.68M	58.44M	230.09M	36.51M	230M	230M	373.66K	16.14M
Total Assets	97.84M	57.72M	86.91M	102.19M	119.48M	131.77M	143.63M	161.43M	180.79M	189.44M	202.36M	230.92M	96.7M	231.66M	231.89M	373.66K	48.34M
Account Payables	1.45M	793K	1.18M	1.62M	1.25M	1.99M	2.58M	2.58M	2.27M	1.77M	5.75M	n/a	5.19M	85.00	n/a	28.00	914K
Deferred Revenue	660K	639K	798K	862K	989K	1.05M	164K	407K	799K	99K	833K	n/a	1.66M	n/a	n/a	n/a	n/a
Short-Term Debt	4.65M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.92M	1.86M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.38M	3.04M	1.32M	1.96M	3.94M	1.8M	3.03M	5.93M	9.26M	7.56M	5.7M	4.05M	3.29M	12.06M	61.02K	349.81K	3.95M
Total Current Liabilities	13.15M	9.06M	9.07M	9.61M	12.67M	10.11M	10.43M	12.87M	18.05M	15.84M	17.8M	4.05M	14.54M	128.84K	61.02K	349.83K	4.87M
Long-Term Debt	28.89M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.05M	2.54M	2.39M	4.04M	6.36M	4.08M	99K	280K	373K	1.09M	1.28M	7.05M	7.05M	8.05M	8.05M	n/a	n/a
Total Long-Term Liabilities	33.94M	32.66M	33.7M	36.48M	39.9M	38.72M	35.79M	36.22M	35.48M	33.26M	30.3M	7.05M	193.62M	8.05M	8.05M	n/a	n/a
Total Liabilities	72.19M	41.73M	42.77M	46.09M	52.57M	48.83M	46.21M	49.09M	53.53M	49.1M	48.1M	11.1M	208.16M	8.18M	8.11M	349.83K	17.4M
Total Debt	33.54M	34.71M	35.74M	36.72M	37.67M	37.31M	38.24M	38.09M	37.09M	34.09M	30.88M	n/a	22.73M	n/a	n/a	n/a	n/a
Common Stock	1K	n/a	1K	5K	5K	4K	4K	4K	4K	4K	4K	230M	1K	230M	230.07M	575.00	1K
Retained Earnings	-297.13M	-296.52M	-267.66M	-256.45M	-244.34M	-225.63M	-210.71M	-192.01M	-173.29M	-155.08M	-138.44M	-10.19M	-115.08M	-6.52M	-6.23M	-1.18K	-59.76M
Comprehensive Income	n/a	n/a	n/a	n/a	-119.48M	n/a	-143.63M	3K	1K	n/a	n/a	-401.83M	-171.83M	-401.83M	n/a	603.00	n/a
Shareholders Equity	25.65M	15.99M	44.15M	56.09M	66.91M	82.94M	97.42M	112.34M	127.26M	140.34M	154.27M	219.81M	-111.46M	223.48M	223.77M	30.95M	30.95M
Total Investments	n/a	n/a	3.55M	4.41M	4.64M	7.45M	22.88M	44.51M	40.94M	1.64M	3.26M	230.03M	230.01M	230M	230M	61.12M	25K